Every material Form 8-K Quanex Building Products has filed with the SEC since June 06, 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Quanex reported net sales of $501.8 million for the three months ended July 31, 2026, up 1.3% from $495.3 million a year earlier, and net income of $26.5 million, or $0.58 per diluted share, compared with a net loss of $276.0 million in the prior-year quarter. The prior-year loss included a $302.3 million non-cash goodwill impairment, so the year-over-year swing largely reflects that charge.
Net sales were $501.8 million, up 1.3% from $495.3 million, mainly due to favorable pricing, partly offset by IEEPA tariff reimbursements to customers.
Diluted EPS was $0.58 versus a loss of $6.04 a year earlier; adjusted diluted EPS was $0.79 versus $0.69.
The company repaid $42.25 million of debt in the quarter and repurchased 99,786 shares for about $1.7 million; about $28.7 million remained under its authorization as of July 31, 2026.
Management will host a conference call on Friday, September 4, 2026, at 11:00 a.m. ET.
Quanex reported results for the three months ended April 30, 2026. Net sales rose 2.2% to $462.4 million, but net income fell to $3.4 million, or $0.07 per diluted share, from $20.5 million, or $0.44, as rapid cost increases and lower volumes pressured margins. Management expects to recover some of the shortfall in the second half if volumes follow normal seasonality and inflationary pressure subsides.
Net sales were $462.4 million, up from $452.5 million, mainly from pricing, including tariff-related recoveries, and foreign exchange.
Gross margin was 25.5% versus 29.0% a year earlier; adjusted diluted EPS was $0.25 versus $0.63.
Adjusted EBITDA was $44.2 million versus $63.1 million in the prior-year quarter.
As of April 30, 2026, total debt was $715.0 million, leverage was 3.1x net debt to LTM adjusted EBITDA, and liquidity was $328.6 million.
Quanex reported first quarter fiscal 2026 results for the three months ended January 31, 2026, with net sales up 2.3% to $409.1 million and a narrower net loss of $4.1 million. Adjusted diluted EPS fell to a loss of $0.01 from earnings of $0.19 a year earlier, and Adjusted EBITDA declined to $27.4 million from $38.5 million. The company also issued fiscal 2026 guidance of $1.84 billion to $1.87 billion in net sales and $240 million to $245 million in Adjusted EBITDA, and said it expects to be a net borrower in the first half of the year.
Net sales rose to $409.1 million from $400.0 million, mainly due to foreign exchange translation and pass-through of tariffs.
Net loss narrowed to $4.1 million, or $0.09 per diluted share, from $14.9 million, or $0.32 per diluted share, a year earlier.
Adjusted EBITDA fell to $27.4 million from $38.5 million, and Adjusted EBITDA margin was 6.7% versus 9.6%.
Fiscal 2026 guidance calls for net sales of $1.84 billion to $1.87 billion and Adjusted EBITDA of $240 million to $245 million, with the first half expected to be more challenging than the first half of 2025.
Quanex reported fourth-quarter and fiscal 2025 results for the period ended October 31, 2025. Fourth-quarter net sales were $489.8 million, down 0.5% from a year earlier, while net income swung to $19.6 million from a loss of $13.9 million, but the full year showed a $250.8 million net loss driven by a $302.3 million goodwill impairment. The company declined to issue formal 2026 guidance, saying fiscal 2026 could be flat with fiscal 2025 on revenue and EBITDA and that it will revisit guidance with its first-quarter results.
Q4 net sales $489.8 million vs $492.2 million a year earlier; Q4 net income $19.6 million, or $0.43 diluted EPS, vs a $13.9 million loss
Full-year net loss of $250.8 million, including a $302.3 million goodwill impairment charge; full-year net sales rose 43.8% to $1.84 billion, mainly from the Tyman acquisition
Q4 adjusted diluted EPS $0.83 vs $0.82; full-year free cash flow $102.3 million and $75 million of bank debt repaid in 2025
No official 2026 guidance; management says fiscal 2026 could be flat with fiscal 2025 on revenue and EBITDA, with the first half likely more challenged
Quanex Building Products named Mary K. Lawler, Senior Vice President and Chief Human Resources Officer of Illinois Tool Works, as a director effective November 1, 2025. The appointment adds a new board member whose term runs to the 2026 annual shareholder meeting, and the filing describes it as routine board refresh rather than a change in company operations.
Mary K. Lawler, age 60, appointed to the Board by the Board of Directors effective November 1, 2025
Term ends at the Company's next annual shareholder meeting, to be held in 2026
Lawler joins the Compensation & Management Development and Nominating & Corporate Governance Committees
Receives an annual Restricted Stock Unit grant on November 3, 2025 under standard director compensation practices
Quanex Building Products appointed Gabriela Garcia as Vice President, Chief Accounting Officer and principal accounting officer, effective October 20, 2025, replacing Karen Ettredge in the principal accounting officer role while Ettredge remains Controller. The filing sets Garcia's base salary at $360,000 with an annual incentive target of 45% of base salary, and the company describes her as having over 25 years of accounting experience, most recently at Rayonier Advanced Materials.
Gabriela Garcia appointed Vice President, Chief Accounting Officer, effective October 20, 2025
Karen Ettredge remains Controller but no longer serves as principal accounting officer
Offer letter sets base salary at $360,000 and annual incentive target at 45% of base salary; long-term incentive target to be determined later
Garcia previously served as Chief Accounting Officer and Corporate Controller at Rayonier Advanced Materials from 2020 to 2025
Quanex reported net sales of $495.3 million for the quarter ended July 31, 2025, up 76.7% from a year earlier, mainly due to the Tyman acquisition. A $302.3 million non-cash goodwill impairment tied to the re-segmentation of the business drove a net loss of $276.0 million, or $6.04 per diluted share, compared with net income of $25.4 million a year earlier. The company also updated its fiscal 2025 guidance to about $1.82 billion in net sales and about $235 million in Adjusted EBITDA.
Q3 net sales $495.3 million, up from $280.3 million; excluding Tyman, sales rose 1.4%
Net loss of $276.0 million, or $6.04 per diluted share, versus $0.77 per share a year earlier
Adjusted diluted EPS $0.69 versus $0.81 a year earlier; Adjusted EBITDA $70.3 million
Fiscal 2025 guidance: net sales of approximately $1.82 billion and Adjusted EBITDA of approximately $235 million
Quanex reported second-quarter results for the three months ended April 30, 2025, with net sales up 70% to $452.5 million, mostly from the Tyman acquisition, while diluted EPS fell to $0.44 from $0.46. The company reaffirmed its fiscal 2025 guidance and raised its cost synergy target to about $45 million, up from $30 million.
Net sales were $452.5 million versus $266.2 million a year earlier; Tyman contributed $190.1 million.
Diluted EPS was $0.44 versus $0.46; adjusted diluted EPS was $0.60 versus $0.73.
Fiscal 2025 guidance reaffirmed: net sales of $1.84 billion to $1.86 billion and Adjusted EBITDA of $270 million to $280 million.
Cost synergy target raised to about $45 million; the company repurchased about $23.5 million of stock in the quarter.
Quanex reported a fiscal first-quarter net loss of $14.9 million, or $0.32 per diluted share, versus net income of $6.2 million, or $0.19 per share, a year earlier, while net sales rose 67.3% to $400.0 million on the Tyman acquisition. The company reaffirmed its fiscal 2025 guidance of $1.84 billion to $1.86 billion in net sales and $270 million to $280 million in Adjusted EBITDA, and it said it has repaid $65 million of debt since closing the Tyman deal on August 1, 2024.
Net sales were $400.0 million for the three months ended January 31, 2025, up from $239.2 million; Tyman contributed $175.7 million, and excluding Tyman, net sales declined 6.2%.
Net loss was $14.9 million, or $0.32 per diluted share, compared with net income of $6.2 million, or $0.19 per share; restructuring charges were $7.9 million.
Adjusted diluted EPS was $0.19, down from $0.25, and Adjusted EBITDA was $38.5 million, up from $19.3 million.
Fiscal 2025 guidance was reaffirmed: net sales of $1.84 billion to $1.86 billion and Adjusted EBITDA of $270 million to $280 million; total debt was $764.3 million as of January 31, 2025.
Quanex reported fourth quarter fiscal 2024 net sales of $492.2 million, up 66.6% from a year earlier, driven by the Tyman acquisition that closed August 1, 2024. The company posted a net loss of $13.9 million, or $0.30 per diluted share, compared with net income of $27.4 million a year earlier, and full-year net income fell to $33.1 million from $82.5 million. Management plans to provide 2025 guidance at a February 6, 2025 Investor and Analyst Day.
Q4 net sales $492.2 million vs. $295.5 million; Q4 diluted EPS loss of $0.30 vs. $0.83 profit
Q4 adjusted diluted EPS $0.61 vs. $0.95 a year earlier; full-year adjusted diluted EPS $2.19 vs. $2.75
Full-year net sales $1.28 billion, up 13.0%; full-year diluted EPS $0.90 vs. $2.50
Debt repaid of $53.75 million in Q4; total debt $776.9 million and liquidity $343.3 million as of October 31, 2024
Quanex reported fiscal third-quarter 2024 results for the three months ended July 31, 2024, with net sales down 6.4% from a year earlier and diluted EPS down to $0.77 from $0.96. The company said prior 2024 guidance no longer applies after the Tyman acquisition closed August 1, 2024, and issued new full-year estimates that include Tyman's contribution.
Net sales were $280.3 million vs. $299.6 million a year earlier; net income was $25.4 million vs. $31.7 million.
Adjusted diluted EPS was $0.73 vs. $0.97; Adjusted EBITDA was $42.0 million vs. $48.5 million.
New fiscal 2024 estimates: net sales of $1.275 billion to $1.285 billion and Adjusted EBITDA of $171 million to $176 million.
Management cited softer demand and lower operating leverage; a conference call is scheduled for September 6, 2024 at 11:00 a.m. ET.
Quanex Building Products appointed two new independent directors, Manish H. Shah and Amit Singhi, effective August 12, 2024, with both joining the Audit Committee. The filing contains no financial results or guidance, so the change is governance-related rather than a direct measure of company performance.
Manish H. Shah, 60, and Amit Singhi, 59, were appointed to the Board on August 12, 2024, each for a term ending at the next annual shareholder meeting in 2024.
Both directors were added to the Audit Committee; they are expected to join the Nominating & Corporate Governance Committee at the next regular Board meeting.
Each director receives an annual Restricted Stock Unit grant on August 12, 2024, pro-rated for length of service, under the company's standard director compensation practices.
Quanex Building Products closed its acquisition of Tyman plc on August 1, 2024. Tyman shareholders receive new Quanex shares and cash, with about 14,139,477 new shares and about $504 million in cash due at closing, which will dilute existing Quanex holders. The filing does not report financial results for the combined company, and pro forma financial information is to follow in a later amendment.
Acquisition closed August 1, 2024; Tyman trading on the London Stock Exchange was suspended that day, and new Quanex shares are scheduled to begin trading on the NYSE on August 2, 2024
Closing consideration: 14,139,477 new Quanex shares and about $504,143,082.86 in cash
Tyman shareholders also receive a 15 pence special interim dividend per share, payable by the 14th day after the scheme became effective
Shareholders approved issuing up to 15,487,381 new Quanex shares at a special meeting on July 12, 2024; pro forma financial information will be filed by amendment
Quanex Building Products amended its existing credit agreement on June 12, 2024 to raise its senior secured revolving credit facility to $475 million and add a $500 million senior secured term loan A. The company says proceeds will be used in part to fund a portion of the purchase price for its planned acquisition of Tyman plc, which was previously announced on April 22, 2024. The new borrowing adds significant debt that shareholders will bear while the Tyman transaction remains subject to completion.
June 12, 2024: amendment to Second Amended and Restated Credit Agreement with Wells Fargo Bank, National Association as agent
Revolving facility of $475 million and term loan A of $500 million, both with a five-year maturity
Term A loan amortizes at 5% per annum; interest at Base Rate plus 1.000% to 1.750% or Adjusted Term SOFR plus 2.000% to 2.750%
Facilities are secured by first-priority liens on substantially all assets and guaranteed by material U.S. subsidiaries
Quanex reported results for the three months ended April 30, 2024, with net sales down 2.7% and GAAP net income and diluted EPS both lower than a year earlier. The company reaffirmed its fiscal 2024 guidance and repaid its remaining $10 million revolver balance. The pending Tyman acquisition, about $1.1 billion in enterprise value, is still expected to close in the second half of 2024, subject to shareholder and regulatory approvals.
Net sales were $266.2 million, down 2.7% from $273.5 million a year earlier, with softer demand in Europe Fenestration and North American Cabinet Components.
Net income was $15.4 million, or $0.46 diluted EPS, versus $21.5 million, or $0.65, a year earlier; adjusted diluted EPS was $0.66, flat year over year.
Fiscal 2024 guidance reaffirmed: net sales of approximately $1.1 billion and Adjusted EBITDA of $145 million to $150 million.
Tyman acquisition expected to close in the second half of 2024; conference call scheduled for June 7, 2024 at 11:00 a.m. ET.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Quanex Building Products filing is on SEC EDGAR ↗. 8-K briefs of other companies →